Vote Scores
Filings read through

Horizon Therapeutics Public Limited Company: how funds voted at the meeting of 27 Jul 2023

Meeting
Season
year to 30 June 2024
Filers reporting
691
Ballot items
5

691 filers on Form N-PX reported votes at the Horizon Therapeutics Public Limited Company meeting of 27 Jul 2023. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Horizon Therapeutics Public Limited Company has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 88.4% of the reported votes are for. 55 filers withheld from or voted against at least one nominee.

    1,146 vote records from 185 filers. 11 of the 185 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 42
    • Against 1
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,012 vote records from 677 filers. 420 of the 646 filers that marked the item voted against management. 31 filers gave no management mark.

    5 filers reported share counts too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 49 fund families
    • For 13
    • Against 36
    • Against management 36
  3. Item 3: Audit-related items (auditor ratification)

    382 vote records from 185 filers. 5 of the 185 filers that marked the item voted against management.

    • Positions of 43 fund families
    • For 43
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    59 vote records from 15 filers. 2 of the 15 filers that marked the item voted against management.

  5. Item 5: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 0 of the 1 filer that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Horizon Therapeutics Public Limited Company, meeting of 27 Jul 2023Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementFor
AllspringAgainst, against managementFor
American CenturyAgainst, against managementFor
BairdAgainst, against managementNo report
BlackRock and iSharesForFor
BNY MellonForFor
Brighthouse FundsAgainst, against managementFor
Capital Group and American FundsForFor
Charles SchwabAgainst, against managementFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalAgainst, against managementFor
DWSAgainst, against managementNo report
EquitableAgainst, against managementFor
Federated HermesForNo report
FidelityAgainst, against managementFor
First TrustAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Global XAgainst, against managementFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
InvescoForFor
J.P. MorganForFor
Jackson National fundsAgainst, against managementFor
Janus HendersonAgainst, against managementNo report
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialAgainst, against managementFor
Macquarie and Delaware FundsAgainst, against managementNo report
MassMutualForNo report
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementFor
Neuberger BermanAgainst, against managementFor
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialAgainst, against managementFor
PIMCOAgainst, against managementFor
PrincipalAgainst, against managementFor
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsAgainst, against managementFor
SEIAgainst, against managementFor
State Street and SPDRForFor
T. Rowe PriceAgainst, against managementFor
TransamericaAgainst, against managementFor
VanguardForFor
Victory CapitalAgainst, against managementFor
VirtusForFor
VoyaAgainst, against managementFor
WisdomTreeAgainst, against managementFor

Questions

How many filers reported votes at the Horizon Therapeutics Public Limited Company meeting?
691 Form N-PX filers reported votes at the meeting of 27 Jul 2023. On say-on-pay, 420 of 646 filers that marked the item voted against management (65.0%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Horizon Therapeutics Public Limited Company reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Horizon Therapeutics Public Limited Company with a meeting date within three days of 27 Jul 2023. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .